Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Mar;109(3):219–224. doi: 10.1289/ehp.01109219

1,N(2)-propanodeoxyguanosine adduct formation in aortic DNA following inhalation of acrolein.

A Penn 1, R Nath 1, J Pan 1, L Chen 1, K Widmer 1, W Henk 1, F L Chung 1
PMCID: PMC1240238  PMID: 11333181

Abstract

Recent reports indicate that many of the cytotoxic and health-threatening components of environmental tobacco smoke (ETS) reside in the vapor phase of the smoke. We have reported previously that inhalation of 1,3-butadiene, a prominent vapor phase component of ETS, accelerates arteriosclerotic plaque development in cockerels. In this study we asked whether inhaled acrolein, a reactive aldehyde that is also a prominent vapor-phase component of ETS, damages artery-wall DNA and accelerates plaque development. Cockerels inhaled 0, 1, or 10 ppm acrolein mixed with HEPA-filtered air for 6 hr. Half were killed immediately (day 1 group) for detection of the stable, premutagenic 1,N(2)-propanodeoxyguanosine acrolein adduct (AdG3) in aortic DNA via a (32)P-postlabeling/HPLC method, and half were killed after 10 days (day 10 group) for indirect assessment of adduct repair. In the day 1 group, acrolein-DNA adducts were 5 times higher in the 1 and 10 ppm groups than in HEPA-filtered air controls. However, in the day 10 group, adduct levels in the 1 and 10 ppm acrolein groups were reduced to the control adduct level. For the plaque studies, cockerels inhaled 1 ppm acrolein (6 hr/day, 8 weeks), mixed with the same HEPA-filtered air inhaled by controls. Plaque development was measured blind by computerized morphometry. Unlike butadiene inhalation, acrolein inhalation did not accelerate plaque development. Thus, even though repeated exposure to acrolein alone has no effect on plaque size under the exposure conditions described here, a single, brief inhalation exposure to acrolein elicits repairable DNA damage to the artery wall. These results suggest that frequent exposure to ETS may lead to persistent artery-wall DNA damage and thus provide sites on which other ETS plaque accelerants can act.

Full Text

The Full Text of this article is available as a PDF (101.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. D., Jr, Klaidman L. K. Acrolein-induced oxygen radical formation. Free Radic Biol Med. 1993 Aug;15(2):187–193. doi: 10.1016/0891-5849(93)90058-3. [DOI] [PubMed] [Google Scholar]
  2. Awasthi S., Boor P. J. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine. Toxicol Lett. 1993 Feb;66(2):157–163. doi: 10.1016/0378-4274(93)90090-k. [DOI] [PubMed] [Google Scholar]
  3. Benditt E. P., Benditt J. M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973 Jun;70(6):1753–1756. doi: 10.1073/pnas.70.6.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burcham P. C., Marnett L. J. Site-specific mutagenesis by a propanodeoxyguanosine adduct carried on an M13 genome. J Biol Chem. 1994 Nov 18;269(46):28844–28850. [PubMed] [Google Scholar]
  5. Chen C., Loo G. Inhibition of lecithin: cholesterol acyltransferase activity in human blood plasma by cigarette smoke extract and reactive aldehydes. J Biochem Toxicol. 1995 Jun;10(3):121–128. doi: 10.1002/jbt.2570100302. [DOI] [PubMed] [Google Scholar]
  6. Chung F. L., Young R., Hecht S. S. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res. 1984 Mar;44(3):990–995. [PubMed] [Google Scholar]
  7. Cohen S. M., Garland E. M., St John M., Okamura T., Smith R. A. Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res. 1992 Jul 1;52(13):3577–3581. [PubMed] [Google Scholar]
  8. Curren R. D., Yang L. L., Conklin P. M., Grafstrom R. C., Harris C. C. Mutagenesis of xeroderma pigmentosum fibroblasts by acrolein. Mutat Res. 1988 Sep-Oct;209(1-2):17–22. doi: 10.1016/0165-7992(88)90104-2. [DOI] [PubMed] [Google Scholar]
  9. ENOS W. F., HOLMES R. H., BEYER J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. J Am Med Assoc. 1953 Jul 18;152(12):1090–1093. doi: 10.1001/jama.1953.03690120006002. [DOI] [PubMed] [Google Scholar]
  10. Esterbauer H., Jürgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 1987 May;28(5):495–509. [PubMed] [Google Scholar]
  11. Foiles P. G., Akerkar S. A., Chung F. L. Application of an immunoassay for cyclic acrolein deoxyguanosine adducts to assess their formation in DNA of Salmonella typhimurium under conditions of mutation induction by acrolein. Carcinogenesis. 1989 Jan;10(1):87–90. doi: 10.1093/carcin/10.1.87. [DOI] [PubMed] [Google Scholar]
  12. Freedman D. S., Newman W. P., 3rd, Tracy R. E., Voors A. E., Srinivasan S. R., Webber L. S., Restrepo C., Strong J. P., Berenson G. S. Black-white differences in aortic fatty streaks in adolescence and early adulthood: the Bogalusa Heart Study. Circulation. 1988 Apr;77(4):856–864. doi: 10.1161/01.cir.77.4.856. [DOI] [PubMed] [Google Scholar]
  13. Hajjar D. P., Pomerantz K. B., Falcone D. J., Weksler B. B., Grant A. J. Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. J Clin Invest. 1987 Nov;80(5):1317–1321. doi: 10.1172/JCI113208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kuykendall J. R., Bogdanffy M. S. Efficiency of DNA-histone crosslinking induced by saturated and unsaturated aldehydes in vitro. Mutat Res. 1992 Oct;283(2):131–136. doi: 10.1016/0165-7992(92)90145-8. [DOI] [PubMed] [Google Scholar]
  15. Majesky M. W., Yang H. Y., Benditt E. P., Juchau M. R. Carcinogenesis and atherogenesis: differences in monooxygenase inducibility and bioactivation of benzo[a]pyrene in aortic and hepatic tissues of atherosclerosis-susceptible versus resistant pigeons. Carcinogenesis. 1983;4(6):647–652. doi: 10.1093/carcin/4.6.647. [DOI] [PubMed] [Google Scholar]
  16. McCall M. R., Tang J. Y., Bielicki J. K., Forte T. M. Inhibition of lecithin-cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes. Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1599–1606. doi: 10.1161/01.atv.15.10.1599. [DOI] [PubMed] [Google Scholar]
  17. Minick C. R., Fabricant C. G., Fabricant J., Litrenta M. M. Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol. 1979 Sep;96(3):673–706. [PMC free article] [PubMed] [Google Scholar]
  18. Moriya M., Zhang W., Johnson F., Grollman A. P. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11899–11903. doi: 10.1073/pnas.91.25.11899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nath R. G., Chung F. L. Detection of exocyclic 1,N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7491–7495. doi: 10.1073/pnas.91.16.7491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nath R. G., Ocando J. E., Chung F. L. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Cancer Res. 1996 Feb 1;56(3):452–456. [PubMed] [Google Scholar]
  21. Nath R. G., Ocando J. E., Guttenplan J. B., Chung F. L. 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Cancer Res. 1998 Feb 15;58(4):581–584. [PubMed] [Google Scholar]
  22. Nelson T. J., Boor P. J. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues. Biochem Pharmacol. 1982 Feb 15;31(4):509–514. doi: 10.1016/0006-2952(82)90152-6. [DOI] [PubMed] [Google Scholar]
  23. Penn A., Chen L. C., Snyder C. A. Inhalation of steady-state sidestream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation. 1994 Sep;90(3):1363–1367. doi: 10.1161/01.cir.90.3.1363. [DOI] [PubMed] [Google Scholar]
  24. Penn A., Keller K., Snyder C., Nadas A., Chen L. C. The tar fraction of cigarette smoke does not promote arteriosclerotic plaque development. Environ Health Perspect. 1996 Oct;104(10):1108–1113. doi: 10.1289/ehp.961041108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Penn A., Snyder C. A. 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation. 1996 Feb 1;93(3):552–557. doi: 10.1161/01.cir.93.3.552. [DOI] [PubMed] [Google Scholar]
  26. Penn A., Snyder C. A. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 1993 Oct;88(4 Pt 1):1820–1825. doi: 10.1161/01.cir.88.4.1820. [DOI] [PubMed] [Google Scholar]
  27. Penn A., Snyder C. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis. 1988 Dec;9(12):2185–2189. doi: 10.1093/carcin/9.12.2185. [DOI] [PubMed] [Google Scholar]
  28. Ramos K. S., Thurlow C. H. Comparative cytotoxic responses of cultured avian and rodent aortic smooth muscle cells to allylamine. J Toxicol Environ Health. 1993 Sep;40(1):61–76. doi: 10.1080/15287399309531776. [DOI] [PubMed] [Google Scholar]
  29. Ramos K. Comparative angiotoxic responses of avian and rodent species in vivo: implications in atherogenesis. J Toxicol Environ Health. 1990;29(4):357–376. doi: 10.1080/15287399009531398. [DOI] [PubMed] [Google Scholar]
  30. Roivainen M., Viik-Kajander M., Palosuo T., Toivanen P., Leinonen M., Saikku P., Tenkanen L., Manninen V., Hovi T., Mänttäri M. Infections, inflammation, and the risk of coronary heart disease. Circulation. 2000 Jan 25;101(3):252–257. doi: 10.1161/01.cir.101.3.252. [DOI] [PubMed] [Google Scholar]
  31. Smith R. A., Cohen S. M., Lawson T. A. Acrolein mutagenicity in the V79 assay. Carcinogenesis. 1990 Mar;11(3):497–498. doi: 10.1093/carcin/11.3.497. [DOI] [PubMed] [Google Scholar]
  32. Steenland K. Passive smoking and the risk of heart disease. JAMA. 1992 Jan 1;267(1):94–99. [PubMed] [Google Scholar]
  33. Steinbrecher U. P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem. 1987 Mar 15;262(8):3603–3608. [PubMed] [Google Scholar]
  34. Taylor A. E., Johnson D. C., Kazemi H. Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation. 1992 Aug;86(2):699–702. doi: 10.1161/01.cir.86.2.699. [DOI] [PubMed] [Google Scholar]
  35. Tejada S. B. Evaluation of silica gel cartridges coated in situ with acidified 2,4-dinitrophenylhydrazine for sampling aldehydes and ketones in air. Int J Environ Anal Chem. 1986;26(2):167–185. doi: 10.1080/03067318608077112. [DOI] [PubMed] [Google Scholar]
  36. Wells A. J. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994 Aug;24(2):546–554. doi: 10.1016/0735-1097(94)90315-8. [DOI] [PubMed] [Google Scholar]
  37. Witschi H., Espiritu I., Maronpot R. R., Pinkerton K. E., Jones A. D. The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis. 1997 Nov;18(11):2035–2042. doi: 10.1093/carcin/18.11.2035. [DOI] [PubMed] [Google Scholar]
  38. Yang Q., Hergenhahn M., Weninger A., Bartsch H. Cigarette smoke induces direct DNA damage in the human B-lymphoid cell line Raji. Carcinogenesis. 1999 Sep;20(9):1769–1775. doi: 10.1093/carcin/20.9.1769. [DOI] [PubMed] [Google Scholar]
  39. Ylä-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989 Oct;84(4):1086–1095. doi: 10.1172/JCI114271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zhu B. Q., Sun Y. P., Sievers R. E., Isenberg W. M., Glantz S. A., Parmley W. W. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993 Jan;21(1):225–232. doi: 10.1016/0735-1097(93)90741-i. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES